Indeed, clinical trials showed that GM-CSF-targeted therapy was efficacious in patients with rheumatoid arthritis who were unresponsive to anti-TNF-α therapy [52, 53]. Furthermore, clinical trials are ongoing or planned to assess the benefits of GM-CSF-targeted therapy for COVID-19 or CAR-T...
20120178090METHOD FOR ISOLATING NUCLEIC ACIDS AND PROTEIN FROM A SINGLE SAMPLEJuly, 2012Bosnes 20110236899Method and Apparatus for Predicting Pharmaceutical Efficacy of Anti-TNFa Antibody Drug Against Rheumatoid ArthritisSeptember, 2011Tsuzaka et al. ...
S Waterman - 《Arthritis & Rheumatism》 被引量: 1019发表: 2000年 Quantitation of CD8+ T-Lymphocyte Responses to Multiple Epitopes from Simian Virus 40 (SV40) Large T Antigen in C57BL/6 Mice Immunized with SV40, SV40 T-An... Epitope I- or II/III- TABLE 1. MHC class I tetramer staini...
The drug is used to prevent or treat malaria infections caused by mosquitos and to treat auto-immune diseases such as lupus and rheumatoid arthritis when other medications have not worked or cannot be used. Read the article New COVID-19 drug therapy guidance from the American Heart Association,...
-- Paul Richard (nonprofit agency: Arthritis Foundation, Indiana Chapter). The chapter serves the 1.4 million adults and 6,400 children in Indiana who live with arthritis. Paul is a key volunteer and fundraiser, serving as captain of Conseco's Jingle Bell Run team in 2008 and 2009, and ...
today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-...